Ashmore Group’s Gilead Sciences GILD Stock Holding History

Ashmore Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,000	Closed	-$72K	–	28
2016 Q4	$72K	Hold	1,000	–	–	0.05%	31
2016 Q3	$78K	Hold	1,000	–	–	0.06%	29
2016 Q2	$83K	Hold	1,000	–	–	0.06%	27
2016 Q1	$92K	Sell	1,000 -1,000	-50%	-$90.2K	0.06%	42
2015 Q4	$202K	Hold	2,000	–	–	0.13%	50
2015 Q3	$196K	Hold	2,000	–	–	0.11%	46
2015 Q2	$234K	Hold	2,000	–	–	0.08%	56
2015 Q1	$196K	Hold	2,000	–	–	0.04%	61
2014 Q4	$189K	Sell	2,000 -3,000	-60%	-$310K	0.04%	53
2014 Q3	$532K	Buy	+5,000	New	+$490K	0.1%	42

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Ashmore Group's GILD Position: Q1 2017 in Review

Ashmore Group sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 1,000 shares — an estimated $72K sold.

Ashmore Group first reported a position in GILD in Q3 2014 and held it in 10 quarters. The position peaked at $532K in Q3 2014. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

Ashmore Group reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
Ashmore Group sold 1,000 Gilead Sciences shares in Q1 2017, an estimated $72K.
Ashmore Group first reported a position in Gilead Sciences in Q3 2014 and held it in 10 quarters.
Ashmore Group's Gilead Sciences position peaked at $532K in Q3 2014.
1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Ashmore Group's 13F filing for Q1 2017, filed 15 May 2017.